30597861|t|Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study.
30597861|a|BACKGROUND: Type 2 diabetes is related to an increased risk of dementia. Preclinical studies of dipeptidyl peptidase-IV inhibitors (DPP-4i) for dementia have yielded promising results. Therefore, we investigated the risk of dementia in elderly patients with type 2 diabetes on DPP-4is and sulfonylureas (SU). METHODS: Using a claims database called the Korean National Health Insurance Service Senior cohort, new users of DPP-4is and SUs were matched by 1:1 propensity score matching using 49 confounding variables (7552 new DPP-4is users and 7552 new SU users were matched by 1:1 propensity score matching; average age 75.4; mean follow-up period: 1361.9 days). Survival analysis was performed to estimate the risk of dementia. RESULTS: The risk of all-cause dementia was lower in the DPP-4i group compared to the SU group (hazard ratio (HR) 0.66; 95% confidence interval (CI) 0.56-0.78; p < 0.001). Particularly, DPP-4i use showed a significantly lower risk of Alzheimer's disease (HR 0.64; 95% CI 0.52-0.79; p < 0.001) and a lower risk, albeit non-significant, of vascular dementia compared to SU use (HR 0.66; 95% CI 0.38-1.14; p = 0.139). CONCLUSION: Our findings suggest that DPP-4i use decreases the risk of dementia compared to SU use in elderly patients with type 2 diabetes in a real-world clinical setting.
30597861	8	16	Dementia	Disease	MESH:D003704
30597861	26	34	Patients	Species	9606
30597861	40	55	Type 2 Diabetes	Disease	MESH:D003924
30597861	101	114	Sulfonylureas	Chemical	MESH:D013453
30597861	172	187	Type 2 diabetes	Disease	MESH:D003924
30597861	223	231	dementia	Disease	MESH:D003704
30597861	292	298	DPP-4i	Chemical	-
30597861	304	312	dementia	Disease	MESH:D003704
30597861	384	392	dementia	Disease	MESH:D003704
30597861	404	412	patients	Species	9606
30597861	418	433	type 2 diabetes	Disease	MESH:D003924
30597861	437	444	DPP-4is	Chemical	-
30597861	449	462	sulfonylureas	Chemical	MESH:D013453
30597861	464	466	SU	Chemical	MESH:D013453
30597861	582	589	DPP-4is	Chemical	-
30597861	685	692	DPP-4is	Chemical	-
30597861	712	714	SU	Chemical	MESH:D013453
30597861	879	887	dementia	Disease	MESH:D003704
30597861	920	928	dementia	Disease	MESH:D003704
30597861	946	952	DPP-4i	Chemical	-
30597861	975	977	SU	Chemical	MESH:D013453
30597861	1075	1081	DPP-4i	Chemical	-
30597861	1123	1142	Alzheimer's disease	Disease	MESH:D000544
30597861	1227	1244	vascular dementia	Disease	MESH:D015140
30597861	1257	1259	SU	Chemical	MESH:D013453
30597861	1342	1348	DPP-4i	Chemical	-
30597861	1375	1383	dementia	Disease	MESH:D003704
30597861	1396	1398	SU	Chemical	MESH:D013453
30597861	1414	1422	patients	Species	9606
30597861	1428	1443	type 2 diabetes	Disease	MESH:D003924
30597861	Negative_Correlation	MESH:D013453	MESH:D003924

